Home>Topics>Companies>GlaxoSmithKline

GlaxoSmithKline

  1. All
  2. Commentary
  3. Video Reports
  4. Headlines
  1. NewLink, GSK get U.S. funding for faster development of Ebola vaccines

    Headlines

    Tue, 23 Dec 2014

    Dec 23 (Reuters) - The U.S. Department of Health and Human Services (HHS) awarded contracts worth a total of about $43 million to NewLink Genetics Corp and GlaxoSmithKline Plc for faster development of two Ebola vaccines.

  2. GSK Ebola vaccine trial seen moving to wider phase in February

    Headlines

    Fri, 19 Dec 2014

    GENEVA, Dec 19 (Reuters) - Trials of GlaxoSmithKline 's experimental Ebola vaccine are likely to move to a second phase in February, later than previously suggested, after a meeting of national...

  3. GSK shareholders approve asset swap deal with Novartis

    Headlines

    Thu, 18 Dec 2014

    LONDON, Dec 18 (Reuters) - Shareholders in British drugmaker GlaxoSmithKline have approved a planned deal with Switzerland's Novartis, which will see the two pharmaceutical groups trade more than $20...

  4. GlaxoSmithKline shingles vaccine hits goal in major study

    Headlines

    Thu, 18 Dec 2014

    LONDON, Dec 18 (Reuters) - An experimental vaccine against shingles from GlaxoSmithKline met its goal in a late-stage study, in a boost for the company's vaccine unit, which is expanding part of its overall healthcare business.

  5. Fitch Affirms GlaxoSmithKline PLC at 'A+'; Revises Outlook to Negative

    Headlines

    Wed, 17 Dec 2014

    has affirmed UK-based pharmaceuticals company GlaxoSmithKline PLC 's ( GSK ) Long-term Issuer Default Rating (IDR) and ..... unsecured rating of 'A+' for the debt issued under GlaxoSmithKline Capital PLC. The Negative Outlook encapsulates

  6. How to Trade Foreign Stocks Without Leaving the U.S.

    Headlines

    Tue, 9 Dec 2014

    traded on U.S. exchanges include such well-known names as Royal Dutch Shell RDS.A, BP BP, Toyota TM, GlaxoSmithKline GSK , and Vodafone VOD. The total value of all ADR shares listed on U.S. exchanges was about $5.4 trillion as

  7. UPDATE 2- GlaxoSmithKline drops plan to sell off older drugs business

    Headlines

    Thu, 4 Dec 2014

    * Sale of established products scrapped after review of bids

  8. GlaxoSmithKline abandons sale of older drugs

    Headlines

    Thu, 4 Dec 2014

    LONDON, Dec 4 (Reuters) - GlaxoSmithKline said on Thursday it had decided not to sell a portfolio of older drugs marketed in North America and Europe after considering offers from potential buyers.

  9. Ebola booster vaccine starts first trials in Oxford

    Headlines

    Thu, 4 Dec 2014

    LONDON, Dec 4 (Reuters) - Scientists at Oxford University have launched the first clinical tests of a new Ebola vaccine approach, using a booster developed by Denmark's Bavarian Nordic that may improve the effects of a shot from GlaxoSmithKline .

  10. GSK cuts U.S. research and sales jobs as market gets tougher

    Headlines

    Thu, 4 Dec 2014

    LONDON (Reuters) - GlaxoSmithKline is to shed hundreds of U.S. commercial and research jobs, restructuring operations in its biggest market where drug sales are flagging.

« Prev12345Next »
Content Partners